Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β2-agonists in Patients with Moderate to Severe Asthma: A Randomized, Controlled Study

被引:3
|
作者
Wang, Yan [1 ]
Chen, Ping [2 ]
Dai, Anna [1 ]
Shang, Shengyun [1 ]
Kong, Lingfei [1 ]
机构
[1] China Med Univ, Hosp 1, Inst Resp Dis, 155 Nanjing North St, Shenyang 110001, Liaoning Provin, Peoples R China
[2] Gen Hosp Shenyang Mil Reg, Resp Med, Shenyang, Liaoning, Peoples R China
关键词
fluticasone aerosol; moderate to severe persistent asthma; salmeterol/fluticasone propionate aerosol; theophylline tablets; treatment; PERSISTENT ASTHMA; LUNG-FUNCTION; BUDESONIDE; THERAPY; MONTELUKAST;
D O I
10.1016/j.clinthera.2016.10.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To evaluate and contrast the therapeutic effect and safety of fluticasone aerosol combined with theophylline tablets in patients with moderate to severe asthma, compared with salmeterol/fluticasone propionate aerosol. Methods: After a screening period, patients meeting the inclusion criteria were randomly assigned to the experiment group (fluticasone aerosol combined with theophylline tablets) or the control group (salmeterol/ fluticasone aerosol combined with placebo tablets) for 12 weeks of treatment. The main outcome measurements were forced expiratory volume in 1 second and fractional concentration of exhaled nitric oxide value, whereas the secondary measures were forced vital capacity, peak expiratory flow value, and Asthma Control Test/Asthma Quality of Life Questionnaire score. Findings: Forty-four cases completed the course, with 23 cases in the experiment group and 21 cases in the control group. The forced expiratory volume in 1 second values of both groups were significantly improved from before (P < 0.05). The fractional concentration of exhaled nitric oxide values of both groups were significantly decreased from before (P < 0.05). The secondary outcome measurements after treatment achieved obvious improvement from baseline (P < 0.05) in both. There was no significant difference between the 2 groups in all measurements. In addition, the blood biochemistry results, ECG results, and vital signs of both groups had no significant abnormality. Implications: There was no significant difference in therapeutic effect and safety between the 2 groups in treating patients with moderate to severe persistent asthma, which suggests that fluticasone aerosol combined with theophylline tablets is worth considering for use in primary hospitals or for low-income populations. (C) 2016 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:2622 / 2627
页数:6
相关论文
共 50 条